Evidence map›Paper›PMID 30040480›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2018

Insulin-like growth factor-II in adipocyte regulation: depot-specific actions suggest a potential role limiting excess visceral adiposity.

Maiadah N Alfares, Claire M Perks, Julian P Hamilton-Shield, Jeffrey M P Holly

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Genes & development · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Cells · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Association of Genetic Variants inFrontiers in endocrinology · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Maiadah N AlfaresInsulin-like Growth Factors and Metabolic Endocrinology Group, Bristol Medical School, Department of Translational Health Sciences, University of Bristol, Learning and Research Building, Southmead Hospital , Bristol , United Kingdom.
Claire M PerksInsulin-like Growth Factors and Metabolic Endocrinology Group, Bristol Medical School, Department of Translational Health Sciences, University of Bristol, Learning and Research Building, Southmead Hospital , Bristol , United Kingdom.
Julian P Hamilton-ShieldNutrition Theme, National Institute of Health Research Bristol Biomedical Research Centre, Bristol Medical School, Department of Translational Health Sciences, University of Bristol, Bristol , United Kingdom.
Jeffrey M P HollyInsulin-like Growth Factors and Metabolic Endocrinology Group, Bristol Medical School, Department of Translational Health Sciences, University of Bristol, Learning and Research Building, Southmead Hospital , Bristol , United Kingdom.
Southmead Hospital · GBUniversity of Bristol · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The IGF system has an important role in growth and development. IGF-II is a recognized fetal growth promoter. However, its physiological postnatal role remains uncertain, although it is maintained in the circulation at a substantially high level throughout life. IGF-II has been strongly linked to obesity in genetic studies, and more recent evidence suggests a metabolic role. We examined fat depot differences in IGF-II's action on differentiation and metabolism. We speculate a specific effect on visceral adipocytes in relation to the differential distribution of insulin receptors between visceral and subcutaneous fat depots. We used a previously established adipocyte, cell culture system of matched pairs of visceral and subcutaneous fat biopsies from 20 normal weight children undergoing routine surgery for nonmalignant, nonseptic conditions. Preadipocytes were differentiated for 14 days in the presence or absence of IGF-II. Oil Red O staining, Western blotting, and reverse transcription polymerase chain reaction techniques were employed to assess levels of adipogenesis markers and levels of the insulin receptor and insulin receptor isoforms. Our data indicate that IGF-II promotes preadipocyte differentiation in subcutaneous preadipocytes but showed a protective, opposing effect restricting visceral preadipocyte differentiation, confirmed by reductions in the differentiation markers peroxisome proliferator-activated receptor gamma and adiponectin and in triglyceride staining. Additionally, IGF-II reduced mRNA expression of the insulin receptor in adipocytes and downregulated insulin receptor isoform A and glucose transporter 4 abundance and corresponding glucose uptake in visceral adipocytes. In conclusion, IGF-II is a regulator of preadipocyte differentiation and metabolism by acting as a differential modulator of fat accumulation favoring less visceral fat deposition in children.

Indexed as

AdipocytesAdipogenesisCells, CulturedChildChild, PreschoolFemaleGlucose Transport Proteins, FacilitativeHumansInfantInfant, NewbornInsulin-Like Growth Factor IIIntra-Abdominal FatMaleReceptor, InsulinGlucose Transport Proteins, FacilitativeInsulin-Like Growth Factor IIReceptor, InsulinadipocyteschildhoodIGFssubcutaneous fatvisceral fat

Identifiers

PMID30040480
PMCPMC6336950
OpenAlexW2883671568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.